Mankind Pharma Limited (MANKIND.BO)
INR 2351.3
(1.6%)
INR 2351.3
(1.6%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 21.51 Billion INR | 32.07% |
| 2022 | 16.17 Billion INR | -15.88% |
| 2021 | 19.23 Billion INR | 15.48% |
| 2020 | 16.65 Billion INR | 10.02% |
| 2019 | 15.13 Billion INR | 74.12% |
| 2018 | 8.69 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 5.74 Billion INR | 18.01% |
| 2023 Q1 | 6.3 Billion INR | 89.91% |
| 2023 Q3 | 5.71 Billion INR | -12.02% |
| 2023 FY | 21.36 Billion INR | 32.07% |
| 2023 Q4 | 4.86 Billion INR | -14.89% |
| 2023 Q2 | 6.49 Billion INR | 2.98% |
| 2022 Q4 | 3.32 Billion INR | -14.9% |
| 2022 Q2 | 5.43 Billion INR | 36.44% |
| 2022 Q3 | 3.9 Billion INR | -28.16% |
| 2022 FY | 16.17 Billion INR | -15.88% |
| 2022 Q1 | 3.98 Billion INR | 59.99% |
| 2021 Q4 | 2.48 Billion INR | 0.0% |
| 2021 FY | 19.23 Billion INR | 15.48% |
| 2020 FY | 16.65 Billion INR | 10.02% |
| 2019 FY | 15.13 Billion INR | 74.12% |
| 2018 FY | 8.69 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 79.37% |
| NATCO Pharma Limited | 25.96 Billion INR | 17.117% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -367.008% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -8533.082% |
| Achyut Healthcare Limited | 4.43 Million INR | -484759.036% |
| Ajanta Pharma Limited | 19.67 Billion INR | -9.355% |
| Alkem Laboratories Limited | 19.46 Billion INR | -10.565% |
| Alpa Laboratories Limited | 184.49 Million INR | -11563.086% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -273.7% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -1152.87% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 49.013% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -1648.012% |
| Brooks Laboratories Limited | 14.44 Million INR | -148916.925% |
| Divi's Laboratories Limited | 33.08 Billion INR | 34.951% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 68.229% |
| Eris Lifesciences Limited | 5.18 Billion INR | -315.268% |
| FDC Limited | 2.98 Billion INR | -620.58% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -230.926% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -139.643% |
| Granules India Limited | 6.81 Billion INR | -215.666% |
| Gufic Biosciences Limited | 1.32 Billion INR | -1518.008% |
| Hester Biosciences Limited | 364.81 Million INR | -5798.425% |
| Indoco Remedies Limited | 1.29 Billion INR | -1564.776% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -386.773% |
| Ipca Laboratories Limited | 7.98 Billion INR | -169.629% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -4134.752% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 14260.614% |
| Lasa Supergenerics Limited | -458 Million INR | 4798.212% |
| Laurus Labs Limited | 3.94 Billion INR | -444.954% |
| Lupin Limited | 28.04 Billion INR | 23.272% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | -21353.683% |
| Megasoft Limited | -121.1 Million INR | 17868.236% |
| Piramal Pharma Limited | 4.55 Billion INR | -372.208% |
| RPG Life Sciences Limited | 2.29 Billion INR | -838.71% |
| Sigachi Industries Limited | 1.47 Billion INR | -1359.943% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 622.912% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | -3676.977% |
| Windlas Biotech Limited | 1.29 Billion INR | -1556.649% |
| ZIM Laboratories Limited | 253.82 Million INR | -8377.378% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 50.082% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -672.363% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -4602.945% |
| Bal Pharma Limited | 233.9 Million INR | -9099.323% |
| Strides Pharma Science Limited | 5.22 Billion INR | -311.765% |
| Venus Remedies Limited | 534.65 Million INR | -3924.69% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -587.891% |
| Nectar Lifesciences Limited | 923.8 Million INR | -2229.282% |
| Shilpa Medicare Limited | 1.36 Billion INR | -1474.946% |
| Aarti Drugs Limited | 7.14 Billion INR | -201.005% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -1247.573% |
| Suven Life Sciences Limited | -1.22 Billion INR | 1855.397% |
| Ind-Swift Limited | 1.22 Billion INR | -1655.194% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | -50.657% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 658.49% |
| Themis Medicare Limited | 392.58 Million INR | -5381.061% |
| Hikal Limited | 32.11 Million INR | -66913.528% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 15.067% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -3334.644% |
| Wockhardt Limited | -670 Million INR | 3311.648% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -314.686% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -237178.155% |
| Neuland Laboratories Limited | 5.31 Billion INR | -304.62% |
| Morepen Laboratories Limited | 4.17 Billion INR | -415.547% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -10242.727% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -78267.121% |